An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion

Abstract Osteoporosis (OP) is a common age-related disease characterized by a deterioration of bone mass and structure that predisposes patients to fragility fractures. Pharmaceutical therapies that promote anabolic bone formation in OP patients and OP-induced fracture are needed. We investigated wh...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gehua Zhen, Yang Dan, Ruomei Wang, Ce Dou, Qiaoyue Guo, Melissa Zarr, Linda N. Liu, Lieping Chen, Ruoxian Deng, Yusheng Li, Zengwu Shao, Xu Cao
Formato: article
Lenguaje:EN
Publicado: Nature Publishing Group 2021
Materias:
Acceso en línea:https://doaj.org/article/a8554920a26d4080a2d68a5e92d3aeba
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a8554920a26d4080a2d68a5e92d3aeba
record_format dspace
spelling oai:doaj.org-article:a8554920a26d4080a2d68a5e92d3aeba2021-11-07T12:09:11ZAn antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion10.1038/s41413-021-00161-12095-6231https://doaj.org/article/a8554920a26d4080a2d68a5e92d3aeba2021-11-01T00:00:00Zhttps://doi.org/10.1038/s41413-021-00161-1https://doaj.org/toc/2095-6231Abstract Osteoporosis (OP) is a common age-related disease characterized by a deterioration of bone mass and structure that predisposes patients to fragility fractures. Pharmaceutical therapies that promote anabolic bone formation in OP patients and OP-induced fracture are needed. We investigated whether a neutralizing antibody against Siglec-15 can simultaneously inhibit bone resorption and stimulate bone formation. We found that the multinucleation of osteoclasts was inhibited in SIGLEC-15 conditional knockout mice and mice undergoing Siglec-15 neutralizing antibody treatment. The secretion of platelet-derived growth factor-BB (PDGF-BB), the number of tartrate-resistant acid phosphatase-positive (TRAP+) mononuclear cells, and bone formation were significantly increased in the SIGLEC-15 conditional knockout mice and antibody-treated mice. The anabolic effect of the Siglec-15 neutralizing antibody on bone formation was blunted in mice with Pdgfb deleted in TRAP+ cells. These findings showed that the anabolic effect of the Siglec-15 neutralizing antibody was mediated by elevating PDGF-BB production of TRAP+ mononuclear cells. To test the therapeutic potential of the Siglec-15 neutralizing antibody, we injected the antibody in an ovariectomy-induced osteoporotic mouse model, which mimics postmenopausal osteoporosis in women, and in two fracture healing models because fracture is the most serious health consequence of osteoporosis. The Siglec-15 neutralizing antibody effectively reduced bone resorption and stimulated bone formation in estrogen deficiency-induced osteoporosis. Of note, the Siglec-15 neutralizing antibody promoted intramembranous and endochondral ossification at the damaged area of cortical bone in fracture healing mouse models. Thus, the Siglec-15 neutralizing antibody shows significant translational potential as a novel therapy for OP and bone fracture.Gehua ZhenYang DanRuomei WangCe DouQiaoyue GuoMelissa ZarrLinda N. LiuLieping ChenRuoxian DengYusheng LiZengwu ShaoXu CaoNature Publishing GrouparticleBiology (General)QH301-705.5PhysiologyQP1-981ENBone Research, Vol 9, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
Physiology
QP1-981
spellingShingle Biology (General)
QH301-705.5
Physiology
QP1-981
Gehua Zhen
Yang Dan
Ruomei Wang
Ce Dou
Qiaoyue Guo
Melissa Zarr
Linda N. Liu
Lieping Chen
Ruoxian Deng
Yusheng Li
Zengwu Shao
Xu Cao
An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion
description Abstract Osteoporosis (OP) is a common age-related disease characterized by a deterioration of bone mass and structure that predisposes patients to fragility fractures. Pharmaceutical therapies that promote anabolic bone formation in OP patients and OP-induced fracture are needed. We investigated whether a neutralizing antibody against Siglec-15 can simultaneously inhibit bone resorption and stimulate bone formation. We found that the multinucleation of osteoclasts was inhibited in SIGLEC-15 conditional knockout mice and mice undergoing Siglec-15 neutralizing antibody treatment. The secretion of platelet-derived growth factor-BB (PDGF-BB), the number of tartrate-resistant acid phosphatase-positive (TRAP+) mononuclear cells, and bone formation were significantly increased in the SIGLEC-15 conditional knockout mice and antibody-treated mice. The anabolic effect of the Siglec-15 neutralizing antibody on bone formation was blunted in mice with Pdgfb deleted in TRAP+ cells. These findings showed that the anabolic effect of the Siglec-15 neutralizing antibody was mediated by elevating PDGF-BB production of TRAP+ mononuclear cells. To test the therapeutic potential of the Siglec-15 neutralizing antibody, we injected the antibody in an ovariectomy-induced osteoporotic mouse model, which mimics postmenopausal osteoporosis in women, and in two fracture healing models because fracture is the most serious health consequence of osteoporosis. The Siglec-15 neutralizing antibody effectively reduced bone resorption and stimulated bone formation in estrogen deficiency-induced osteoporosis. Of note, the Siglec-15 neutralizing antibody promoted intramembranous and endochondral ossification at the damaged area of cortical bone in fracture healing mouse models. Thus, the Siglec-15 neutralizing antibody shows significant translational potential as a novel therapy for OP and bone fracture.
format article
author Gehua Zhen
Yang Dan
Ruomei Wang
Ce Dou
Qiaoyue Guo
Melissa Zarr
Linda N. Liu
Lieping Chen
Ruoxian Deng
Yusheng Li
Zengwu Shao
Xu Cao
author_facet Gehua Zhen
Yang Dan
Ruomei Wang
Ce Dou
Qiaoyue Guo
Melissa Zarr
Linda N. Liu
Lieping Chen
Ruoxian Deng
Yusheng Li
Zengwu Shao
Xu Cao
author_sort Gehua Zhen
title An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion
title_short An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion
title_full An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion
title_fullStr An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion
title_full_unstemmed An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion
title_sort antibody against siglec-15 promotes bone formation and fracture healing by increasing trap+ mononuclear cells and pdgf-bb secretion
publisher Nature Publishing Group
publishDate 2021
url https://doaj.org/article/a8554920a26d4080a2d68a5e92d3aeba
work_keys_str_mv AT gehuazhen anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT yangdan anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT ruomeiwang anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT cedou anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT qiaoyueguo anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT melissazarr anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT lindanliu anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT liepingchen anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT ruoxiandeng anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT yushengli anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT zengwushao anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT xucao anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT gehuazhen antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT yangdan antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT ruomeiwang antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT cedou antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT qiaoyueguo antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT melissazarr antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT lindanliu antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT liepingchen antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT ruoxiandeng antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT yushengli antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT zengwushao antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
AT xucao antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion
_version_ 1718443507559956480